Mayne Pharma break-up may be best medicine say investors
MELBOURNE: The battle for Mayne Pharma was a headline grabber in 2025: a dramatic intervention
MELBOURNE: The battle for Mayne Pharma was a headline grabber in 2025: a dramatic intervention
FEATURED
21-year-old with autism defies odds with paid job
BorderPlus maps out global expansion with training-first healthcare mobility model
Disabled air travellers still face barriers despite existing regulations
Guidebook to boost employment opportunities for persons with disabilities
Family of disabled twins sue Virgin over bathroom refusal
Grieving mother creates app to connect fellow bereaved parents